Home | Business News | Browse by Publication | P | Pharma Marketletter

AstraZeneca reports promising Seroquel SR data from schizophrenia studies.

Publication: Pharma Marketletter
Publication Date: 26-MAR-07
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Anglo-Swedish drug major AstraZeneca says that data from trials of a sustained-release formulation of Seroquel (quetiapine fumarate), indicate that a once-daily administration of the drug significantly improves the symptoms associated with schizophrenia. In addition, the results showed that treatment, when given as part of a three-step dosing program designed to reach an effective dose on the second day, increased the time to psychiatric...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
Iraq's Red Crescent demands $238M blood compensation.(Brief article), April 02, 2007
345% rise in spend from Ph I to II development.(Brief article)(Statist..., April 02, 2007
Pharmos gets $1.5M grant for Israeli govt.(Brief article), April 02, 2007
United Thera and Mochida sign Remodulin deal for Japan.(Mochida Pharma..., April 02, 2007
BioCell's Collagen II passes toxicology tests.(Brief article), April 02, 2007

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.